BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1331 related articles for article (PubMed ID: 17200597)

  • 21. Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.
    Yeom HS; Shepard DS
    J Ment Health Policy Econ; 2007 Dec; 10(4):207-19. PubMed ID: 18166831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is gastric electrical stimulation superior to standard pharmacologic therapy in improving GI symptoms, healthcare resources, and long-term health care benefits?
    Cutts TF; Luo J; Starkebaum W; Rashed H; Abell TL
    Neurogastroenterol Motil; 2005 Feb; 17(1):35-43. PubMed ID: 15670262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of expanded mental health benefits on treatment costs.
    Sasso AT; Lurie IZ; Lee JU; Lindrooth RC
    J Ment Health Policy Econ; 2006 Mar; 9(1):25-33. PubMed ID: 16733269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
    Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
    J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variation in use and costs of primary health and social services in mental health or drinking problems.
    Forma L; Jarvala T; Ahonen J; Vitikainen K; Rissanen P
    J Ment Health Policy Econ; 2009 Jun; 12(2):79-86. PubMed ID: 19567933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Managed care and the quality of substance abuse treatment.
    Shepard DS; Daley M; Ritter GA; Hodgkin D; Beinecke RH
    J Ment Health Policy Econ; 2002 Dec; 5(4):163-74. PubMed ID: 14578550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substitution between Formal and Informal Care for Persons with Severe Mental Illness and Substance Use Disorders.
    Clark RE; Xie H; Adachi-Mejia AM; Sengupta A
    J Ment Health Policy Econ; 2001 Sep; 4(3):123-132. PubMed ID: 11967472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Migration, mental health and costs consequences in Romania.
    Miclutia I; Junjan V; Popescu CA; Tigan S
    J Ment Health Policy Econ; 2007 Mar; 10(1):43-50. PubMed ID: 17417046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Managed care, networks and trends in hospital care for mental health and substance abuse treatment in Massachusetts: 1994-1999.
    Fleming E; Lien H; Ma CT; McGuire TG
    J Ment Health Policy Econ; 2003 Mar; 6(1):3-12. PubMed ID: 14578543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of group psychotherapy for depression in Uganda.
    Siskind D; Baingana F; Kim J
    J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost of care of schizophrenia: a study of Indian out-patient attenders.
    Grover S; Avasthi A; Chakrabarti S; Bhansali A; Kulhara P
    Acta Psychiatr Scand; 2005 Jul; 112(1):54-63. PubMed ID: 15952946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population.
    Tournier M; Moride Y; Crott R; du Fort GG; Ducruet T
    J Affect Disord; 2009 May; 115(1-2):160-6. PubMed ID: 18694602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A cost-effectiveness and cost-utility study of lung transplantation.
    Vasiliadis HM; Collet JP; Penrod JR; Ferraro P; Poirier C
    J Heart Lung Transplant; 2005 Sep; 24(9):1275-83. PubMed ID: 16143245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SAFE Homes: is it worth the cost? An evaluation of a group home permanency planning program for children who first enter out-of-home care.
    DeSena AD; Murphy RA; Douglas-Palumberi H; Blau G; Kelly B; Horwitz SM; Kaufman J
    Child Abuse Negl; 2005 Jun; 29(6):627-43. PubMed ID: 15979706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guideline recommendations for treatment of schizophrenia: the impact of managed care.
    Dickey B; Normand SL; Hermann RC; Eisen SV; Cortes DE; Cleary PD; Ware N
    Arch Gen Psychiatry; 2003 Apr; 60(4):340-8. PubMed ID: 12695310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cost of relapse in patients with schizophrenia in the European SOHO (Schizophrenia Outpatient Health Outcomes) study.
    Hong J; Windmeijer F; Novick D; Haro JM; Brown J
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(5):835-41. PubMed ID: 19351551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utilization and cost impact of integrating substance abuse treatment and primary care.
    Parthasarathy S; Mertens J; Moore C; Weisner C
    Med Care; 2003 Mar; 41(3):357-67. PubMed ID: 12618639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The economic effect of a tertiary hospital-based heart failure program.
    Gregory D; DeNofrio D; Konstam MA
    J Am Coll Cardiol; 2005 Aug; 46(4):660-6. PubMed ID: 16098432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The implementation of managed behavioral healthcare in Colorado and the effects on older Medicaid beneficiaries.
    Kaskie B; Wallace N; Kang S; Bloom J
    J Ment Health Policy Econ; 2006 Mar; 9(1):15-24. PubMed ID: 16733268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 67.